NSC 57148 is a selective Grb7 SH2 domain antagonist with an IC50 value of 1.1 µM. NSC 57148 reduces cancer cell proliferation and migration. NSC 57148 is promising for research of Grb7-overexpressing malignancies such as breast and pancreatic cancers[1].
Molecular Weight:
553.48
CAS Number:
[4315-44-0]
Formula:
C28H30Cl2N6O2
Target:
EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted